Skip to main content
Year archive

Medartis Holding AG — 2024 filings

All 20 regulatory filings released by Medartis Holding AG (MED) in 2024, sourced directly from the official regulator.

20 Filings
2024 Period
2024 filings (20)
Filing Released Lang
Jahresabschluss zum Geschäftsjahr vom 01.10.2022 bis zum 30.09.2023
Audit Report / Information FY 2023
2024-10-18 German
Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) improvement of EBITDA* margin to 17%
Earnings Release H1 2024
2024-08-20 English
Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17%
Earnings Release H1 2024
2024-08-20 English
Medartis verzeichnet ein Umsatzwachstum von 13% auf Gruppenebene, angetrieben durch starkes regionales Wachstum in den USA (21%) und EMEA (18%)  –  EBITDA*-Marge stieg auf 17%
Earnings Release H1 2024
2024-08-20 German
Basel, 9th July 2024 Matthias Schupp appointed as CEO of Medartis
Board/Management Information
2024-07-09 English
Basel, 9th July 2024   Matthias Schupp appointed as CEO of Medartis
Board/Management Information
2024-07-09 English
Basel, 9. Juli 2024   Matthias Schupp zum CEO von Medartis ernannt
Board/Management Information
2024-07-09 German
Basel, 11th June 2024 Medartis announces resignation of CEO Christoph Bronnimann
Board/Management Information
2024-06-11 English
Basel, 11th June 2024   Medartis announces resignation of CEO Christoph Brönnimann
Board/Management Information
2024-06-11 English
Basel, 11. Juni 2024   Medartis gibt den Rücktritt von CEO Christoph Brönnimann bekannt
Board/Management Information
2024-06-11 German
Medartis successfully places CHF 115.8 million convertible bonds due 2031
Capital/Financing Update
2024-04-04 English
Medartis successfully places CHF 115.8 million convertible bonds due 2031
Capital/Financing Update
2024-04-04 English
Medartis platziert erfolgreich Wandelanleihen in Höhe von CHF 115,8 Mio. mit Fälligkeit 2031
Capital/Financing Update
2024-04-04 German
Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031
Capital/Financing Update
2024-04-03 English
Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031
Capital/Financing Update
2024-04-03 English
Medartis lanciert eine vorrangige Wandelanleihe im Rahmen einer Privatplatzierung in Höhe von rund CHF 115 Mio. mit Fälligkeit 2031
Capital/Financing Update
2024-04-03 German
Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%
Earnings Release FY 2023
2024-03-12 English
Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%
Earnings Release FY 2023
2024-03-12 English
Medartis steigert den Umsatz um 21% (kWk) und verbessert die normalisierte EBITDA-Marge auf 16%
Earnings Release FY 2023
2024-03-12 German
Annual Report 2023
Annual Report FY 2023
2024-03-08 English